CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,225,000 | +57.1% | 680,855 | +289.1% | 0.02% | +88.9% |
| Q3 2021 | $780,000 | -84.8% | 175,000 | -80.3% | 0.01% | -86.6% |
| Q2 2021 | $5,147,000 | +4897.1% | 887,500 | +4008.8% | 0.07% | +3250.0% |
| Q4 2020 | $103,000 | -72.8% | 21,600 | -66.9% | 0.00% | -77.8% |
| Q3 2020 | $379,000 | -88.9% | 65,300 | -87.1% | 0.01% | -92.1% |
| Q2 2020 | $3,426,000 | -53.7% | 507,500 | -56.4% | 0.11% | -72.8% |
| Q1 2020 | $7,406,000 | -41.6% | 1,164,300 | -4.3% | 0.42% | -1.4% |
| Q4 2019 | $12,680,000 | +379.8% | 1,216,300 | +80.7% | 0.42% | +210.2% |
| Q3 2019 | $2,643,000 | -1.2% | 673,000 | +273.9% | 0.14% | +1.5% |
| Q2 2019 | $2,676,000 | -74.0% | 180,000 | -56.5% | 0.14% | -76.1% |
| Q1 2019 | $10,276,000 | +436.6% | 414,100 | +535.1% | 0.57% | +434.0% |
| Q3 2018 | $1,915,000 | – | 65,200 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |